with disparate functions, including tissueresident, embryonically derived macrophages and infiltrating monocyte-derived macrophages (8, (11) (12) (13) . The normal heart is seeded with resident macrophages derived from yolk sac and embryonic progenitors that are not replenished by circulating monocytes under steady-state conditions (11, 14) . Resident cardiac macrophages are minimally inflammatory and promote angiogenesis and tissue repair. However, cardiac injury and aging stimulate the infiltration of monocyte-derived macrophages that are proinflammatory, promote tissue injury, and the death and substitution of resident cells (11) (12) (13) (14) . Monocytederived macrophages can be distinguished by the expression of C-C chemokine receptor 2 (CCR2), which critically regulates their mobilization and recruitment in response to C-C motif chemokine ligand 2 (CCL2), also known as monocyte chemoattractant protein-1 (8, 11, 15, 16 ).
Although we and others have documented expansion of cardiac macrophages during the early phase of pressure overload (9, 17, 18) , it is unknown whether the macrophages are monocyte-derived, and whether these cells play an important role in subsequent T-cell recruitment and activation, and associated long-term adverse cardiac remodeling. Accordingly, here we tested the hypothesis that CCR2 þ monocyte-derived macrophages infiltrate the heart early following pressure-overload-induced hemodynamic stress, and that this macrophage population plays a critical role in the activation of T cells and the ensuing transition to failure.
METHODS
MICE. C57BL/6 male mice (#000664) were purchased from Jackson Laboratories (Bar Harbor, Maine). All mice were maintained at the University of Alabama at
Birmingham in accordance with Institutional Animal
Care and Use Committee guidelines. All surgeries were performed in 10-to 12-week-old male mice. A total of 162 mice were used for these studies.
TAC AND EXPERIMENTAL PROTOCOL. TAC surgery or a sham operation was performed as previously described (9) . For studies of pharmacological CCR2
inhibition, sham and TAC mice were treated intraperitoneally (i.p.) with 2 mg/kg RS-504393 (selective spiropiperidine small molecule CCR2 receptor antagonist [19] , Tocris Bioscience, Bristol, United Kingdom) or vehicle control twice daily (20) on days 3 to 7 postsurgery. For studies of antibody-mediated depletion of CCR2 þ cells, we used MC21, a monoclonal antibody developed against murine CCR2 (15) . Sham and TAC mice were given i.p. injections of 20-mg anti-CCR2 monoclonal antibody (21, 22) or IgG control on days 3 to 5 post-surgery. We next assessed cardiac macrophage populations adapting gating strategies reported to distinguish resident and infiltrating cells (11) (12) (13) . Supplemental increase specificity, and defined macrophages as Figure 1B ). There was a significant increase in total CD45 þ leukocytes and total macrophages in the heart 1 week post-TAC ( Figure 1C ).
When examining resident and infiltrating subsets, we
found an w4-fold increase in CCR2 À macrophages and an w8-fold increase in CCR2 þ macrophages in TAC hearts as compared with sham ( Figure 1C ). Interestingly, despite the marked differences in macrophage abundance, both sham and TAC hearts exhibited a preponderance of CCR2 þ macrophages (unlike naive hearts), suggesting that both surgery and mechanical Patel et al. , and CD3 þ CD8 þ T-lymphocytes in mediastinal lymph nodes (MLNs) from the same animal groups. *p < 0.05, **p < 0.01, ***p < 0.001; n ¼ 6 to 9 per group. We next sought to determine the importance of infiltrating CCR2 þ macrophages for remodeling progression and the transition to failure using both Patel et al.
pharmacological and antibody-based approaches.
Mice were treated in a circumscribed fashion with the CCR2 antagonist RS-504393 early after TAC (3 to 7 days), and the mice were followed until the chronic stage (4 weeks) post-TAC ( Figure 3A) . As shown in Table 1 Figure 6A shows the gating strategy used to identify 
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CCR2
+ Macrophages and Heart Failure CD3 þ CD4 þ T cells and CD4 þ Th1, Th2, and Treg subsets. As depicted in Figure 6B , IgG-treated TAC mice exhibited a 3-to 4-fold absolute increase in CD4 Abbreviations as in Table 1 . Because we observed monocyte-derived macrophage infiltration early after TAC, we sought to evaluate its functional importance by pursuing interventions during the early phase of pressure overload, before the late transition to HF. We first tested the effects of RS-504393, a small molecule that selectively interferes with the interaction between CCL2 and CCR2 with high affinity (19) . Notably, CCR2
blockade early after TAC did not impact circulating STUDY LIMITATIONS. We did not specifically assess the effects of CCR2 þ macrophage ablation after the transition to HF, given that our prior studies of immune cell profiling indicated cardiac macrophage expansion was primarily an early event after TAC (9).
Additionally, we did not examine the impact of CCR2 inhibition on circulating T-cell populations, because only a minority (2% to 15%) of T cells express CCR2 (15) . Importantly, in this regard, we perturbed the CCR2 axis early during pressure overload (within 1 week post-TAC), a time point before substantial cardiac T-cell infiltration (7) . 
CONCLUSIONS

